David Lee Johnson

Global Blood Therapeutics, Inc.Vera Therapeutics, Inc.

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 1 saleMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€91k

Latest filing published 25 Feb 2026 for Vera Therapeutics, Inc., €91k. Read the official filing

Filing timeline

BuySale

David Lee Johnson

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

David Lee Johnson: trading record in brief

David Lee Johnson discloses dealings in 2 companies, chiefly Global Blood Therapeutics, Inc. and Vera Therapeutics, Inc. The record holds 13 filings, for trades running from 1 August 2021 to 23 February 2026.

Every open-market trade on record is a sale: 1 sale worth €91k. Besides market trades, the filings include 5 share grants and 6 option exercises. So far in 2026, the count stands at no purchases and 1 sale.

The record was last updated on 25 February 2026 with an open-market sale (€91k) in Vera Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.